Results 11 to 20 of about 112,704 (293)
Diffusion of Botulinum Toxins [PDF]
Tremor and Other Hyperkinetic Movements, 2012 Background: It is generally agreed that diffusion of botulinum toxin occurs, but the extent of the spread and its clinical importance are disputed.
Matthew A. Brodsky +2 more
doaj +6 more sources
Toxins, 2020 Botulinum toxins (BoNTs) are a true wonder of nature [...]
Siro Luvisetto
doaj +2 more sources
Indian Journal of Dermatology, 2010 Botulinum toxin, one of the most poisonous biological substances known, is a neurotoxin produced by the bacterium Clostridium botulinum. C. botulinum elaborates eight antigenically distinguishable exotoxins (A, B, C 1 , C 2 , D, E, F and G).
Nigam P, Nigam Anjana
doaj +3 more sources
Bacterial Toxins, Current Perspectives
Toxins, 2020 Toxins are the major pathogenicity factors produced by numerous bacteria involved in severe diseases in humans and animals. Certain pathogenic bacteria synthesize only one toxin which is responsible for all the symptoms and outcome of the disease.
Michel R. Popoff
doaj +2 more sources
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review [PDF]
Toxins, 2021 Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis.
Emanuela Martina +4 more
doaj +2 more sources
Korean botulinum toxins. [PDF]
J Neural Transm (Vienna)Abstract Botulinum toxin (BT) is used therapeutically since the late 1980s. For many years, BT drugs were provided by a small group of manufacturers from Europe and the United States. As BT’s use for aesthetic purposes surged, numerous new manufacturers entered the field, particularly from Korea.
Dressler D +3 more
europepmc +3 more sources
Utilities of Botulinum Toxins in Dermatology and Cosmetology [PDF]
Clinical, Cosmetic and Investigational Dermatology, 2021 Piyu Parth Naik
exaly +2 more sources
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. [PDF]
Toxins (Basel), 2020 In 2016, the American Academy of Neurology (AAN) published practice guidelines for botulinum toxin (BoNT) in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. This article, focusing on dystonia, provides context for these
Spiegel LL, Ostrem JL, Bledsoe IO.
europepmc +2 more sources
Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches. [PDF]
Toxins (Basel), 2019 International audienceBotulinum neurotoxin (BoNT) is produced by the anaerobic, Gram-positive bacterium Clostridium botulinum. As one of the most poisonous toxins known and a potential bioterrosism agent, BoNT is characterized by a complex mode of action
Rasetti-Escargueil C, Popoff MR.
europepmc +2 more sources
Variability of Botulinum Toxins: Challenges and Opportunities for the Future. [PDF]
Toxins (Basel), 2018 Botulinum neurotoxins (BoNTs) are the most potent known toxins, and are therefore classified as extremely harmful biological weapons. However, BoNTs are therapeutic drugs that are widely used and have an increasing number of applications.
Rasetti-Escargueil C +2 more
europepmc +2 more sources